Moberg Pharma AB (OMX: MOB) today announces that a new terbinafine supplier has been secured for MOB-015 (drug for nail fungus). As a result, terbinafine availability is no longer a limiting factor ...

Teva Pharmaceutical Industries Ltd. ADR 1.14% $25.35B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. Read More ...

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 38,530.56 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

GSK has axed a Phase 2 study of a chron­ic he­pati­tis B ther­a­peu­tic vac­cine, adding to a string of treat­ment R&D hur­dles for the liv­er … ...

GSK has made another trip to China to build out its antibody-drug conjugate (ADC) pipeline, returning with an option on a preclinical Duality Biologics candidate that could ultimately cost the Big ...